hiv treatment

Novel therapeutic targets for HIV

harminka — Thu, 02 Oct 2008 12:35:38 -0500

The Salk Institute for Biological Studies and Burnham Institute for Medical Research today announced 295 host cell factors that are involved in human immunodeficiency virus (HIV) infection.

Evaluating cost-effectiveness of genetic screening to guide initial HIV treatment

harminka — Thu, 18 Sep 2008 07:54:18 -0500

A major study from a team of researchers from Weill Cornell Medical College and Massachusetts General Hospital has found that a recent change to HIV-treatment guidelines recommending genetic screening is cost-effective under certain conditions.

Help from herpes? Coinfection induces acyclovir to inhibit HIV

harminka — Wed, 10 Sep 2008 12:27:35 -0500

A surprising interaction may enable development of new HIV treatment strategies by exploiting infection with multiple pathogens. The research, published by Cell Press in the September 11th issue of the journal Cell Host and Microbe, demonstrates that a drug commonly used to treat herpes directly suppresses HIV in coinfected tissues and thus may be beneficial for patients infected with both viruses.

Overlooked tool in battle against HIV/AIDS

harminka — Fri, 08 Aug 2008 00:56:49 -0500

The links between HIV transmission and the degree to which people are able to adopt realistic plans to achieve future projects, in other words, hope, have been overlooked in policies to tackle HIV/AIDS. New research funded by the Economic and Social Research Council (ESRC) argues that hope is a powerful tool in the battle to stop the spread of HIV/AIDS.

Researchers halt spread of HIV with RNAi

harminka — Thu, 07 Aug 2008 13:20:52 -0500

Hopes languished last September when a promising candidate HIV vaccine failed to work. Despite this setback, many researchers still believe immunization is possible, and a new study suggests they're correct—at least at the cellular level.

Why treatment isn't effective for HIV

harminka — Wed, 06 Aug 2008 08:00:15 -0500

University of Minnesota researchers have answered a key question as to why antiretroviral therapy isn't effective in restoring immunity in HIV-infected patients.

Novel method to create personalized immunotherapy treatments

harminka — Wed, 06 Aug 2008 07:56:19 -0500

Argos Therapeutics and Université de Montréal today announced the presentation of new information on Argos'process for developing dendritic cell-based immunotherapies for HIV.

Certain HIV treatment less effective when used with anti-Tuberculosis therapy

harminka — Sun, 03 Aug 2008 13:24:15 -0500

Patients receiving rifampicin-based anti-tuberculosis therapy are more likely to experience virological failure when starting nevirapine-based antiretroviral therapy, an HIV treatment that is widely used in developing countries because of lower cost, than when starting efavirenz-based antiretroviral therapy, according to a study in the August 6 issue of JAMA, a theme issue on HIV/AIDS.

Growth hormone reduces abdominal fat, cardiovascular risk in HIV patients

harminka — Sun, 03 Aug 2008 13:21:08 -0500

Low-dose growth hormone treatment reduced abdominal fat deposits and improved blood pressure and triglyceride levels in a group of patients with HIV lipodystrophy, a condition involving the redistribution of fat and other metabolic changes in patients receiving combination drug therapy for HIV infection.

US Researchers Discover Possible Treatment For HIV Infection

admin_huliq — Fri, 01 Aug 2008 21:42:21 -0500

On the eve of the International AIDS Conference, which begins in Mexico City Sunday, researchers at the University of Texas Medical School at Houston claim to have discovered a way to destroy the HIV virus that causes AIDS. If their hopes are confirmed in further tests, it could represent a major breakthrough in fighting the deadly disease. But, as VOA's Greg Flakus reports from Houston, much work needs to be done to test the theory.

urgent recommendations in advance of global AIDS conference

harminka — Fri, 01 Aug 2008 09:40:38 -0500

With tens of thousands due to gather in Mexico City Aug. 3 for the 2008 International AIDS Conference, the journal AIDS has published a special supplement that provides concrete recommendations for addressing the complex social and economic issues that fuel HIV.

New therapy for HIV treatment

harminka — Wed, 30 Jul 2008 00:48:14 -0500

Millions of people world-wide who have contracted a highly resistant strain of HIV could benefit from a new drug to treat the infection, according to UNSW research.